Alphabet/Google Isn’t Evil but Genetically Modifying Mosquitos Might Be
By Mic Wright,
The Next Web
| 08. 25. 2015
Untitled Document
Blah blah don’t be evil blah blah blah. At some point, Google’s unofficial motto became like the message printed inside a stick of British seaside rock (see here for details, international readers). It’s a glib thing and chewing down on it too hard is apt to rot your teeth or perhaps your brain.
Google isn’t evil, anymore than any other corporation is evil. Watch the documentary, ‘The Corporation’ and you’ll hear a compelling argument that companies behave in a manner that is similar to sociopaths, but the individuals within Google/Alphabet genuinely do believe they are engaged in important, world-changing work – even the ones shovelling ads at your eyeballs.
But there’s a problem with people convinced they are engaged with a noble purpose. The old cliché that everyone is the hero of their own story and that no villain truly sees themselves as one is worth thinking about when it comes to boundary-pushing science.
In science fiction, we’re often confronted with inventors and experimenters who do something horrific because they thought they were acting in the interests of the greater...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...